Supplements - Safety
Supplement safety and medication interactions
Last updated 1 October 2026. How we write this .
Supplements can change how medicines are absorbed, broken down or act in the body. Safety depends on the ingredients, the person and the strength of the interaction evidence.
Start here Supplements can change how medicines are absorbed, broken down or act in the body. Safety depends on the ingredients, the person and the strength of the interaction evidence.
By the end, you will understand What counts as an interaction? How supplements change medicine exposure How effects can add up or oppose each other Key words used in this lesson Sequence The specific order of amino acids in a peptide. The sequence determines the shape the molecule takes and therefore what it can bind to, which is why changing one amino acid can change a compound entirely. MHRA The Medicines and Healthcare products Regulatory Agency, the UK body responsible for assessing medicines and medical devices and for enforcing medicines law. Yellow Card scheme The UK system for reporting suspected side effects of medicines and problems with medical devices. Reports can be submitted by patients as well as healthcare professionals. Full plain-English glossary
Where this information comes from Claim-cited evidence. Central research claims on this lesson are linked to specific studies or official guidance.
This lesson links the specific studies and guidance used for its central claims.
Our standard: expert or athlete opinion may illustrate a viewpoint, but it is never treated as proof. Read the editorial policy .
Report an error or outdated claim .
Supplements can change how medicines work by altering their absorption, breakdown or effects on the body. They can influence clotting, blood pressure and sedation, while overlapping ingredients across products can increase exposure unintentionally. Judging safety means looking at the exact product, the person's medicines and health, and how strong the evidence is for each possible interaction.
What counts as an interaction?
An interaction occurs when one substance changes the effect of another. A supplement might increase a medicine's effects, weaken them or make unwanted effects more likely. An interaction can also reduce the supplement's absorption. The important question is whether the combination produces a meaningful change, rather than simply whether both products affect the same biological pathway.
Supplements include vitamins, minerals, plant extracts and mixtures sold as powders, capsules, gummies or drinks. These categories describe what a product contains, not how safe it is alongside medicines. A nutrient that the body needs can still cause problems through excess exposure or an interaction.
An adverse effect is different: a supplement can cause harm without interacting with anything else. Contamination, an undeclared ingredient or an unexpectedly concentrated extract can create further risks. These distinctions matter because checking a medicine interaction list cannot establish every aspect of product safety.
How supplements change medicine exposure
The first route is absorption. Some minerals can bind certain medicines in the gut, leaving less available to enter the bloodstream. Calcium and iron can interfere with the absorption of levothyroxine, a thyroid hormone medicine. Levothyroxine is prescription-only in the UK; questions about combinations belong with a GP or pharmacist, rather than an improvised timing arrangement.
Calcium, iron and magnesium can also reduce the absorption of some antibiotics.
The second route involves enzymes, proteins that carry out chemical reactions. Enzymes in the gut and liver help process many medicines. Some supplement ingredients increase enzyme activity, potentially lowering medicine concentrations. Others inhibit particular enzymes, potentially increasing exposure. The direction and importance of the effect depend on the specific medicine and pathway.
Transport proteins also matter. They move substances across cell boundaries and can affect how much medicine reaches the circulation or leaves a tissue. St John's wort is a well-established example of a herbal product that can alter medicine exposure through enzyme and transport pathways. The MHRA has highlighted clinically important interactions with hormonal contraception and epilepsy medicines.
These mechanisms explain why simply separating products in time is not a universal solution. An effect on enzyme activity can persist beyond the time an ingredient is in the gut. A combination needs assessment of its mechanism, not a generic rule about spacing.
How effects can add up or oppose each other
Some interactions change what a medicine does without changing its concentration. If two substances both promote drowsiness or lower blood pressure, their effects may add together. The outcome depends on the ingredients and the person; a shared mechanism suggests a possibility, but does not by itself establish how often harm occurs.
Opposing effects are also possible. Warfarin reduces the body's ability to recycle vitamin K for making functional clotting proteins. Vitamin K supplements can therefore counter its anticoagulant effect. This is an established interaction, not merely a laboratory theory. Warfarin is prescription-only in the UK, and supplement questions require a GP, pharmacist or anticoagulation team's assessment.
This does not mean every product described as affecting clotting has the same evidence or risk. Laboratory effects on platelets do not automatically translate into clinically important bleeding. Broad statements that all herbal products 'thin the blood' obscure differences between ingredients, preparations and the human evidence.
A supplement can interfere with a test as well as with a medicine. The MHRA warns that biotin can distort some thyroid blood test results. A misleading result can resemble a change in health even when it reflects interference with the laboratory method.
What the evidence can actually establish
Evidence is strongest when human studies show a reproducible change in medicine exposure or a relevant clinical outcome, supported by a plausible mechanism. Small controlled interaction studies can measure blood concentrations carefully. However, a study in healthy volunteers may not show what happens in older people, people with illness or those taking several medicines.
Large randomised trials can help establish benefits and common harms, but many supplement combinations have never undergone such testing. Trials designed to assess effectiveness may exclude people taking interacting medicines. Their reassuring safety findings therefore cannot automatically be extended to the people excluded.
Case reports describe suspected problems in individuals. They can reveal important warning signals, particularly when a product was not studied widely before use. However, they cannot reliably measure how common a problem is or exclude every alternative explanation. Observational studies offer broader experience but can be affected by differences in health and medicine use.
Cell and animal experiments help identify possible mechanisms. They may use exposures that people would not experience, so they cannot establish the size of a human risk on their own. For many mixtures, evidence remains thin. 'No interaction reported' may mean nobody has investigated or recognised it, rather than that safety has been demonstrated.
Why the same product has different risks
People taking several medicines have more possible combinations to assess. Risk also matters more when a medicine has a narrow margin between an effective exposure and a harmful one. Liver or kidney impairment can change how substances are processed or cleared, making evidence from healthy adults less transferable.
Pregnancy, breastfeeding and childhood require separate consideration because adult evidence may not apply. Before surgery or a procedure, supplement information also matters because clotting and sedation are relevant. A product used uneventfully by a healthy adult is not evidence of safety in these circumstances.
Someone taking no medicines has fewer opportunities for medication interactions, but can still experience ingredient duplication, allergy or toxicity. Conversely, a supplement recommended for an identified nutritional need has a different benefit-risk context from an untested mixture promoted for general optimisation. Neither context removes the need to understand the ingredients.
People with diabetes or another condition managed with medicines should bring supplement questions to their care team. Consumer devices cannot confirm that a combination is safe, and medicines should not be changed on the basis of a consumer device reading. Prescribed medicines should not be started, stopped or changed because of supplement claims.
A useful record and a meaningful quality check
A complete product record makes a professional review more informative. Recording existing use is different from deciding what someone should take. The NHS advises checking herbal products with a pharmacist when other medicines are involved, including medicines available without a prescription.
Record every supplement and medicine, including occasional products, with its name, labelled strength and the amount actually used. Keep the full ingredient list or a clear photograph of the packaging; a brand name alone may cover several formulations. Include powders, gummies and drinks, because the same vitamin, mineral or stimulant may appear in several products. Note when each product entered the routine and when any new symptoms appeared. Bring this information to a pharmacist or care team so the whole combination can be assessed. Independent quality testing can reduce uncertainty about identity, labelled content or particular contaminants, depending on what was tested. A useful certificate identifies the product or batch, the laboratory and the scope of testing. A vague 'tested' badge gives much less information.
Quality testing cannot demonstrate that a product works or that it is compatible with someone's medicines. Likewise, 'natural', 'food-based' and 'traditional' describe origin or marketing, not freedom from biological effects. A concentrated extract may have a very different composition from the plant used as food.
Judging claims and recognising warning signs
A credible interaction claim identifies the ingredient, preparation, medicine and evidence type. It distinguishes a measured human effect from a theoretical concern and acknowledges uncertainty. Claims about a blend need evidence relevant to that blend; research on one ingredient cannot establish the safety of all its combinations.
New symptoms after a supplement warrant stopping the activity if continuing is unsafe and seeking advice, rather than pushing through. Call 999 for sudden throat or tongue swelling, difficulty breathing or collapse. Contact NHS 111 for urgent concerns such as unusual bleeding, or a GP for persistent, non-urgent symptoms. These routes support assessment without changing prescribed medicines independently.
Suspected adverse effects involving medicines or herbal products can be reported through the MHRA's Yellow Card scheme, directly or with a healthcare professional. Proof is not required: reports help identify patterns, although an individual report does not establish causation. Product details and the sequence of events make reports more useful; reporting does not replace seeking help.
This lesson is general education, not medical advice. Seek qualified advice if you have symptoms or a medical condition, are pregnant, or take regular medicines.
Related in this classroom Related in other classrooms The studies behind this page Food supplements guidance: medicines, pregnancy and medical conditions - UK GovernmentSources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.